Dublin, Ireland

Fintan Keegan

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Fintan Keegan: Innovator in Nasal Drug Delivery Systems

Introduction

Fintan Keegan is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of pharmaceutical innovations, particularly in the development of nasal drug delivery systems. With a total of four patents to his name, Keegan's work focuses on addressing critical health issues, including opioid overdose treatment.

Latest Patents

Fintan Keegan's latest patents include innovative nasal drug products and methods of their use. These drug products are specifically adapted for nasal delivery and comprise a pre-primed device filled with a pharmaceutical composition that includes an opioid receptor antagonist. His patents provide methods for treating opioid overdose or its symptoms using these inventive drug products, showcasing his commitment to improving healthcare solutions.

Career Highlights

Throughout his career, Fintan Keegan has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Adapt Pharma Limited and Opiant Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to the development of life-saving medical products.

Collaborations

Fintan Keegan has collaborated with esteemed professionals in his field, including Robert Gerard Bell and Roger Crystal. These partnerships have further enhanced his innovative capabilities and have played a role in the successful development of his patented technologies.

Conclusion

Fintan Keegan stands out as a significant figure in the realm of nasal drug delivery systems. His innovative patents and collaborations reflect his dedication to advancing pharmaceutical solutions for critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…